関節内補充療法市場：製品、供給源、用途、最終用途別-2024-2030年の世界予測

関節内補充療法市場規模は2023年に28億3,000万米ドルと推計され、2024年には30億1,000万米ドルに達し、CAGR 6.19％で2030年には43億2,000万米ドルに達すると予測されます。

関節内補充療法は、変形性関節症などの症状による痛みを和らげるために、膝などの関節にヒアルロン酸を注入する医療処置です。非外科的治療の選択肢として、関節内補充療法は関節機能を改善し、痛みを軽減し、場合によっては人工関節置換術を遅らせることを目的としています。関節障害やスポーツ関連傷害の増加、こうした病気にかかりやすい高齢者人口の増加、低侵襲手術への嗜好の高まりなどが、市場の成長に大きく寄与しています。しかし、ステロイド注射や非薬物療法を含む代替治療オプションの存在は、市場の成長を阻害する可能性があります。とはいえ、ヒアルロン酸の製剤化と送達における技術的進歩やヘルスケアインフラの改善は、関節内補充療法市場の開拓に潜在的な機会を生み出すと期待されています。

製品変形性関節症患者の疼痛軽減と運動能力向上のための3回注射レジメンの採用が急増しています。

5回注射レジメンは、5回のヒアルロン酸（HA）注射からなる関節内補充療法治療法です。この治療コースは通常、週1回、5週間連続で行われます。主に変形性膝関節症の治療に用いられ、関節内の滑液の潤滑性とクッション性を回復させることを目的としています。単回注射レジメンは、関節内補充療法に代わるアプローチとして、1回だけの注射という利便性を提供します。この製品には高濃度のヒアルロン酸が配合されており、関節内での治療の耐久性と持続性を高める架橋剤が含まれていることが多いです。3回注射レジメンは、広く採用されている関節内補充療法治療法で、ヒアルロン酸注射を3回シリーズで行います。これらは通常1週間間隔で行われ、関節腔内の滑液の粘性を補うようにデザインされています。この治療の第一の目的は、変形性関節症患者の痛みを和らげ、可動性を高めることです。3回注射のレジメンは、より広範な5回注射のコースと1回注射の代替治療との間のバランスを取り、治療への取り組みと症状緩和の期間という点で中間的な位置を提供しています。

出典過敏反応のリスクを排除するため、動物由来でないヒアルロン酸への嗜好が高まる

動物由来のヒアルロン酸は、関節内補充療法のヒアルロン酸を得るための一次情報でした。動物由来の供給源は、ヒアルロン酸を豊富に含む雄鶏の櫛の組織を利用するか、他の鳥類の組織から抽出したものです。動物由来でないヒアルロン酸は、細菌発酵プロセスにより生産されます。高純度のHAを生合成するために、Streptococcus zooepidemicusのような遺伝子組み換え菌株が使用されます。非動物性HAは安全で効果的であると考えられ、過敏反応を引き起こす可能性のある鳥類タンパク質に関連したリスクを排除しています。さらに、非動物由来のHAは、倫理的配慮と生産における一貫性から人気を集めています。

応用例変形性膝関節症に対する関節内補充療法治療の進化した応用例

変形性手関節症に対する関節内補充療法治療では、ヒアルロン酸を患部の関節に直接注入します。この治療は、痛み止めや理学療法などの従来の非外科的治療で十分な効果が得られなかった場合に行われます。変形性手関節症に対する関節内補充療法の主な利点は、痛みの軽減にあり、その結果、機能と生活の質の向上にあります。関節内補充療法は、変形性股関節症患者、特に従来の治療法に反応しなかった患者の痛みを軽減し、機能性を改善する治療法として証明されています。股関節の処置はより複雑であり、股関節が深部にあるため、しばしば超音波やX線によるガイドを必要とします。変形性股関節症における関節内補充療法の主な利点は、非ステロイド性抗炎症薬（NSAIDs）の長期使用と比較して、その優れた安全性プロファイルです。変形性膝関節症は関節内補充療法の最も一般的な用途です。膝は体重を支える主要な関節であるため、摩耗や損傷の影響を非常に受けやすいからです。関節内補充療法処置は、変形性膝関節症によって失われた滑液の自然な性質を回復させることを目的としています。

最終用途整形外科クリニック／外来手術センター（ASC）における関節内補充療法治療の利用拡大

病院は、変形性関節症、特に膝関節に悩む患者の治療オプションである関節内補充療法の重要なエンドユーズセクターです。集学的アプローチを行う総合医療施設である病院は、この低侵襲手術を提供する上で極めて重要です。関節内補充療法では、ヒアルロン酸を関節内に注入することで、関節を潤滑にし、痛みを和らげ、可動性を向上させる。整形外科クリニックと外来手術センター（ASC）は、関節内補充療法が頻繁に投与される特殊な最終使用環境です。これらのセンターは、筋骨格系の健康に重点を置いているため、関節内補充療法のような的を絞った治療を提供するのに非常に適しています。ASCは、利便性、効率性、そして一般的に低コストであることから、外来治療を求める患者にとって魅力的な選択肢となっています。

地域別の洞察

変形性関節症の罹患率の増加、医療費の高騰、低侵襲治療への嗜好の高まり、FDA認可のHA製品の普及により、市場は南北アメリカで発展しています。先進ヘルスケアシステム、変形性関節症治療オプションに対する意識の高まり、そして支持的な規制の枠組みが、欧州における関節内補充療法市場の成長を促しています。中東・アフリカの関節内補充療法市場は、治療の入手しやすさと価格の改善、変形性関節症に対する競合治療法の普及によって成長しています。アジア太平洋地域は、変形性関節症の有病率が高く、ヘルスケアインフラが拡大し、高度な変形性関節症治療へのアクセスが増加しているため、関節内補充療法に対する需要が大きいです。また、関節内補充療法治療の有効性を向上させるための継続的な調査により、関節内補充療法市場の世界の需要が促進されると予想されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは関節内補充療法市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、関節内補充療法市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.関節内補充療法市場の市場規模および予測は？

2.関節内補充療法市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.関節内補充療法市場の技術動向と規制枠組みは？

4.関節内補充療法市場における主要ベンダーの市場シェアは？

5.関節内補充療法市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 変形性関節症に対する非外科的治療の必要性の高まり
    • 食習慣の変化による生活習慣病の発生増加
    • 世界の高齢者人口と肥満の急増
  • 抑制要因
    • ヒアルロン酸ベースの治療の副作用と高額な費用
  • 機会
    • ヒアルロン酸ベースの治療法の開発における継続的な進歩
    • 膝蓋軟骨症における関節内補充療法の役割の拡大
  • 課題
    • 承認のための厳格な規制義務と潤滑および鎮痛の持続期間の短さ
• 市場セグメンテーション分析
  • 製品：変形性関節症患者の痛みを軽減し、可動性を高めるための3回注射療法の採用が急増
  • 出典：過敏症反応のリスクを排除するため、非動物由来のヒアルロン酸が好まれる傾向が高まっている
  • アプリケーション：変形性膝関節症に対する関節内補充療法治療の応用の進化
  • 最終用途：整形外科クリニック/外来手術センター（ASC）における関節内補充療法治療の利用の拡大
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 関節内補充療法市場：製品別

• 5回の注射
• 単回注射
• 3回の注射

第7章 関節内補充療法市場：ソース別

• 動物
• 非動物

第8章 関節内補充療法市場：用途別

• 手の変形性関節症
• 変形性股関節症
• 変形性膝関節症

第9章 関節内補充療法市場：最終用途別

• 病院
• 整形外科クリニック/外来手術センター（ASC）

第10章 南北アメリカの関節内補充療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の関節内補充療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの関節内補充療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • KiOmed PharmaとArsylabは、難治性膝関節症の新しい治療薬であるKioMedinevsoneのフランスにおける販売促進と流通に関する戦略的提携を発表
  • アニカのシンガルが第3相試験で主要評価項目を達成

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
• FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 53. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 54. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 55. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 56. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 57. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 60. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 61. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 64. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 65. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 68. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 69. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 70. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 71. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 72. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 73. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 76. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 77. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 78. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 79. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 80. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 81. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 84. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 88. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 90. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 94. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 97. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 100. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 101. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 104. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 105. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 106. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 107. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 108. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 109. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 116. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 117. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 120. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 121. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 122. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 123. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 124. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 125. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 126. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 127. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 128. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 129. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 130. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 131. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 132. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 133. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 136. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 137. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 140. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 141. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 144. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 145. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 146. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 147. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 148. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 149. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 152. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 153. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 154. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 155. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 156. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 157. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 160. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 162. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 164. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 169. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 172. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 173. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 176. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 177. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 178. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 179. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 180. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 181. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 184. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 185. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 188. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 189. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 192. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 203. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 204. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 205. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 206. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 207. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 210. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 211. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 214. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 215. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 218. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 219. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 220. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 221. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 222. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 223. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 226. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 227. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 230. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 231. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 234. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 235. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 238. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 239. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 242. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 243. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 246. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 247. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 248. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 249. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 250. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 251. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 252. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 253. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 254. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 255. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 256. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 257. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 258. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 259. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 262. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 263. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 266. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 267. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 270. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 271. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 274. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 275. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 276. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 277. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 278. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 279. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 282. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 283. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 286. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 287. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 288. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 289. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 290. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 291. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 292. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 293. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 294. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 295. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 296. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 297. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 298. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 299. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 302. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 303. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 304. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 305. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 306. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 310. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 312. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 314. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 315. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 316. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 318. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 320. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 322. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 323. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 324. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 325. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 326. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 327. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 328. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 329. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 330. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 331. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 332. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 333. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 334. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 335. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 336. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 337. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 338. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 339. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 340. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 341. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 342. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 343. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 344. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 345. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 346. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 347. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 348. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 349. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 350. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
• TABLE 351. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 352. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 353. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 354. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 355. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 356. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 357. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
• TABLE 358. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030

[184 Pages Report] The Viscosupplementation Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.01 billion in 2024, at a CAGR 6.19% to reach USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into a joint, such as the knee, to relieve pain caused by conditions such as osteoarthritis. As a non-surgical treatment option, viscosupplementation aims to improve joint function, reduce pain, and possibly delay joint replacement surgery. Increasing incidences of joint disorders and sport-related injuries, a growing elderly population that is more susceptible to such ailments, and the rising preference for minimally invasive procedures significantly contribute to market growth. However, the existence of alternative treatment options, including steroid injections and non-pharmacologic therapies, may impede market growth. Nevertheless, technological advancements in formulating and delivering hyaluronic acid and healthcare infrastructure improvements are expected to create potential opportunities for developing the viscosupplementation market.

Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis

The five-injection regimen is a viscosupplementation treatment consisting of five hyaluronic acid (HA) injections. This course of therapy is typically administered once per week over five consecutive weeks. Primarily used for the management of knee osteoarthritis, this treatment aims to restore the lubricating and cushioning properties of the synovial fluid in the joint. The Single-Injection Regimen offers an alternative approach to viscosupplementation with the convenience of a one-time injection. This product is formulated with a high concentration of hyaluronic acid and often includes cross-linking agents that enhance the durability and longevity of the treatment within the joint. The Three-Injection Regimen is a widely adopted viscosupplementation treatment that involves a series of three hyaluronic acid injections. These are typically administered one week apart and are designed to supplement the viscous properties of synovial fluid in the joint space. The primary goal of this treatment is to relieve pain and enhance mobility in patients with osteoarthritis. The three-injection regimen strikes a balance between the more extensive five-injection course and the single-injection alternative, offering a middle ground in terms of treatment commitment and duration of symptom relief.

Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks

Animal-based sources have been the primary means of obtaining hyaluronic acid for viscosupplementation. Animal-based sources utilize tissues from rooster combs, which are rich in hyaluronic acid or are extracted from other avian tissues. Non-animal-based hyaluronic acid is produced through bacterial fermentation processes. Genetically modified strains of bacteria, such as Streptococcus zooepidemicus, are used to biosynthesize high-purity HA. Non-animal HA is considered safe and effective, eliminating the risks associated with avian proteins that can cause hypersensitivity reactions. Additionally, non-animal-based HA has been gaining popularity due to ethical considerations and consistency in production.

Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis

Hyaluronic acid is directly injected into the affected joint in the viscosupplementation treatment for hand osteoarthritis. This treatment is used when traditional non-surgical treatments such as pain medications and physical therapy have not provided adequate relief. The main benefit of viscosupplementation for hand osteoarthritis lies in its pain reduction and, hence, improvement in function and quality of life. Viscosupplementation is a proven therapeutic measure to alleviate pain and improve functionality in patients with hip osteoarthritis, particularly those not responding to conventional treatments. The procedure for the hip joint is more complex, often requiring ultrasound or X-ray guidance due to the hip's deep-seated nature. A key advantage of viscosupplementation in hip osteoarthritis is its superior safety profile compared to long-term use of non-steroidal anti-inflammatory drugs (NSAIDs). Knee osteoarthritis is the most common application for viscosupplementation since the knee is a major weight-bearing joint and, therefore, is highly susceptible to wear and tear. The viscosupplementation procedure aims to restore the natural properties of the synovial fluid lost to knee osteoarthritis.

End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)

Hospitals represent a significant end-use sector for viscosupplementation, a therapeutic option for patients suffering from osteoarthritis, particularly in the knee joint. As comprehensive medical facilities with a multidisciplinary approach, hospitals are pivotal in providing this minimally invasive procedure. Viscosupplementation involves the intra-articular injection of hyaluronic acid to lubricate the joint, alleviate pain, and improve mobility. Orthopedic clinics and Ambulatory Surgical Centers (ASCs) are specialized end-use settings where viscosupplementation is frequently administered. These centers are predominantly focused on musculoskeletal health, making them highly adept at providing targeted therapies like viscosupplementation. The convenience, efficiency, and typically lower costs associated with ASCs make them an attractive option for patients seeking outpatient care.

Regional Insights

The market is evolving in the Americas owing to the growing incidence of osteoarthritis, high healthcare expenditure, increasing preference for minimally invasive procedures, and widespread availability of several FDA-approved HA products. Advanced healthcare systems, increased awareness about osteoarthritis treatment options, and supportive regulatory frameworks are encouraging the growth of the viscosupplementation market in Europe. The Middle East and Africa viscosupplementation market is growing with improving availability and affordability of treatment and the prevalence of competitive treatment modalities for osteoarthritis. The Asia Pacific region represents significant demand for viscosupplementation due to high osteoarthritis prevalence, expanding healthcare infrastructure, and increasing accessibility to advanced osteoarthritis treatments. Besides, ongoing research to improve the efficacy of viscosupplementation therapy is anticipated to propel the demand for the viscosupplementation market globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viscosupplementation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viscosupplementation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., DePuy Synthes by Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Chem Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Five Injection
  • Single Injection
  • Three Injection

• Source
  • Animal
  • Non-animal

• Application
  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Knee Osteoarthritis

• End-use
  • Hospitals
  • Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Viscosupplementation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viscosupplementation Market?

3. What are the technology trends and regulatory frameworks in the Viscosupplementation Market?

4. What is the market share of the leading vendors in the Viscosupplementation Market?

5. Which modes and strategic moves are suitable for entering the Viscosupplementation Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
    • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
    • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
    • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
  • 5.1.4. Challenges
    • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
  • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
  • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
  • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Viscosupplementation Market, by Product

• 6.1. Introduction
• 6.2. Five Injection
• 6.3. Single Injection
• 6.4. Three Injection

7. Viscosupplementation Market, by Source

• 7.1. Introduction
• 7.2. Animal
• 7.3. Non-animal

8. Viscosupplementation Market, by Application

• 8.1. Introduction
• 8.2. Hand Osteoarthritis
• 8.3. Hip Osteoarthritis
• 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Viscosupplementation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
  • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio